Why the study?
The study aimed to describe baseline characteristics of patients with oral anticoagulant-related intracerebral hemorrhage (OAC-ICH) in Sweden and identify predictive variables associated with receiving hemostatic reversal treatment.
What patient factors are associated with receiving reversal therapy in oral anticoagulant-related intracerebral hemorrhage?
Population
1902 patients with OAC-ICH in Sweden during 2017-2019
Comparison
OAC reversal treatment vs no OAC reversal treatment
Design
Registry-based observational study
Authors
Loading...
Variables linked to reversal in OAC-ICH should not yet alter practice; leaves open need for prospective outcome validation.
What patient factors are associated with receiving reversal therapy in oral anticoagulant-related intracerebral hemorrhage?
In patients with oral anticoagulant-related intracerebral hemorrhage, NOAC use, older age, previous stroke, and comatose state were associated with lower odds of receiving reversal therapy.
Apostolaki‐Hansson et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: